Ther­mo Fish­er reels in pro­teomics com­pa­ny Olink in $3.1B deal

Ther­mo Fish­er is set to in­crease its pro­teomics of­fer­ing through the pur­chase of Olink in a deal worth $3.1 bil­lion.

The Swedish com­pa­ny, which start­ed in 2016, of­fers a suite of pro­teomics-based ser­vices de­signed to help phar­ma com­pa­nies and aca­d­e­m­ic re­searchers in their pro­tein bio­mark­er dis­cov­ery and drug de­vel­op­ment. Olink’s $OLK share price jumped 65% up­on the an­nounce­ment.

The con­glom­er­ate’s buy­out pro­pos­al val­ues Olink at $26 per com­mon share, which is about 74% of the pro­teom­ic play­er’s clos­ing price on Mon­day. The $3.1 bil­lion ten­der of­fer fac­tors in $143 mil­lion in cash that Olink al­ready has. Olink’s rev­enue is cur­rent­ly pro­ject­ed to ex­ceed $200 mil­lion next year, ac­cord­ing to a press re­lease.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER